Millennium Pharmaceuticals

Millennium Pharmaceuticals was a biopharmaceutical company based in Cambridge, Massachusetts, focused on oncology and inflammation, best known for developing the cancer drug Velcade (bortezomib). Backed early by Kleiner Perkins, it was acquired by Takeda Pharmaceutical Company in 2008 for $8.8B and its brand was retired to "Takeda Oncology" in 2013; it no longer operates as an independent company. Surfaced in the API Evangelist network as a VC-portfolio stub. This is a research/company profile with no independent developer API surface — the pipeline confirmed the provider publishes no public API, developer portal, SDKs, or event/webhook surface.

Millennium Pharmaceuticals is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Biopharmaceutical, Oncology, and Pharmaceuticals.

🌐 Visit website 📡 Source on GitHub

5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyHealthcareBiopharmaceuticalOncologyPharmaceuticalsLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 5.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/millennium-pharmaceuticals: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Source (apis.yml)

aid: millennium-pharmaceuticals
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/millennium-pharmaceuticals.png
name: Millennium Pharmaceuticals
description: Millennium Pharmaceuticals was a biopharmaceutical company based in Cambridge, Massachusetts, focused on oncology
  and inflammation, best known for developing the cancer drug Velcade (bortezomib). Backed early by Kleiner Perkins, it was
  acquired by Takeda Pharmaceutical Company in 2008 for $8.8B and its brand was retired to "Takeda Oncology" in 2013; it no
  longer operates as an independent company. Surfaced in the API Evangelist network as a VC-portfolio stub. This is a research/company
  profile with no independent developer API surface — the pipeline confirmed the provider publishes no public API, developer
  portal, SDKs, or event/webhook surface.
url: https://raw.githubusercontent.com/api-evangelist/millennium-pharmaceuticals/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- kleiner-perkins
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Healthcare
- Biopharmaceutical
- Oncology
- Pharmaceuticals
- Life Sciences
apis: []
x-note: Defunct as an independent entity; acquired by Takeda (2008), rebranded Takeda Oncology (2013). No first-party developer
  API surface exists to enrich.
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1